Metraipolis › archive › dc_ed37576efb2b

BAR12: Bayesian Autoregressive Phase 1-2 Design for Cell Therapy Trials With Manufacturing Changes — Europe PMC PMID:42009580

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42009580
DOI: 10.1002/sim.70551
License (as archived): solo-consultazione
Archived: 2026-11-03T14:09:27.345Z
SHA-256 of the archived text: 035131db37988a1c4285e6ea9cb00d75d057d9045fa045360d290df2460888a6
Stable URL of this page: https://metraipolis.com/documento/dc_ed37576efb2b

How to cite

BAR12: Bayesian Autoregressive Phase 1-2 Design for Cell Therapy Trials With Manufacturing Changes — Europe PMC PMID:42009580 — Europe PMC (en), https://europepmc.org/article/MED/42009580 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ed37576efb2b (Metraipolis archive dc_ed37576efb2b, sha256 035131db37988a1c4285e6ea9cb00d75d057d9045fa045360d290df2460888a6)

BibTeX

@misc{dced37576efb2b,
  title = {BAR12: Bayesian Autoregressive Phase 1-2 Design for Cell Therapy Trials With Manufacturing Changes — Europe PMC PMID:42009580},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42009580},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ed37576efb2b; sha256 035131db37988a1c4285e6ea9cb00d75d057d9045fa045360d290df2460888a6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42009580. Agents can read the archived copy with the MCP tool read_document.